Question 1: what are the options for treating latent TB infection in children?

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 2013-06, Vol.98 (6), p.468-474
Main Authors: Gwee, Amanda, Coghlan, Benjamin, Curtis, Nigel
Format: Article
Language:English
Subjects:
Age groups
Antitubercular Agents - administration & dosage
Antitubercular Agents - adverse effects
Child
Child, Preschool
Cohort analysis
Dose-Response Relationship, Drug
Drug dosages
Grade 2
Grade 3
Humans
Information Seeking
Isoniazid - administration & dosage
Isoniazid - adverse effects
Latent Tuberculosis - drug therapy
Minicourses
Observational studies
Patients
Pediatrics
Randomized Controlled Trials as Topic
Rifampin - administration & dosage
Rifampin - adverse effects
Search Strategies
Tuberculosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783
cites cdi_FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783
container_end_page 474
container_issue 6
container_start_page 468
container_title Archives of disease in childhood
container_volume 98
creator Gwee, Amanda
Coghlan, Benjamin
Curtis, Nigel
description
doi_str_mv 10.1136/archdischild-2013-303876
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1350153332</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1350153332</sourcerecordid><originalsourceid>FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783</originalsourceid><addsrcrecordid>eNpdkF9LwzAUxYMobk6_ggR88aWa5CZp6ovo8B8MRZjPIW0T19G1M0kRv73tNkV8unA4595zfwhhSi4oBXlpfLEoq1AsqrpMGKGQAAGVyj00plyqXuJ8H40JIZBkSqkROgphSQhlSsEhGjGQkkqZjtHza2dDrNoG0yv8uTARG29xXFjcrgc5YNd6HL01sWrecW2ibSKe3-KqcbbYBKsGb4p421wfowNn6mBPdnOC3u7v5tPHZPby8DS9mSUFEyomUojcGcG44jJnXBqe0ZS4DAqbQaaEo8Sw3JCUsBKKXBjrUkakVIoRBqmCCTrf7l379mP4QK96HLauTWPbLmgKglABAKy3nv2zLtvON307TRVTGUtFynuX2roK34bgrdNrX62M_9KU6IG5_stcD8z1lnkfPd0d6PKVLX-DP5DhG2Nbflw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828927574</pqid></control><display><type>article</type><title>Question 1: what are the options for treating latent TB infection in children?</title><source>Social Science Premium Collection</source><source>Education Collection</source><creator>Gwee, Amanda ; Coghlan, Benjamin ; Curtis, Nigel</creator><creatorcontrib>Gwee, Amanda ; Coghlan, Benjamin ; Curtis, Nigel</creatorcontrib><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2013-303876</identifier><identifier>PMID: 23661667</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Age groups ; Antitubercular Agents - administration &amp; dosage ; Antitubercular Agents - adverse effects ; Child ; Child, Preschool ; Cohort analysis ; Dose-Response Relationship, Drug ; Drug dosages ; Grade 2 ; Grade 3 ; Humans ; Information Seeking ; Isoniazid - administration &amp; dosage ; Isoniazid - adverse effects ; Latent Tuberculosis - drug therapy ; Minicourses ; Observational studies ; Patients ; Pediatrics ; Randomized Controlled Trials as Topic ; Rifampin - administration &amp; dosage ; Rifampin - adverse effects ; Search Strategies ; Tuberculosis</subject><ispartof>Archives of disease in childhood, 2013-06, Vol.98 (6), p.468-474</ispartof><rights>Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783</citedby><cites>FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1828927574/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1828927574?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,21359,21375,27905,27906,33592,33593,33858,33859,43714,43861,73970,74146</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23661667$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gwee, Amanda</creatorcontrib><creatorcontrib>Coghlan, Benjamin</creatorcontrib><creatorcontrib>Curtis, Nigel</creatorcontrib><title>Question 1: what are the options for treating latent TB infection in children?</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><subject>Age groups</subject><subject>Antitubercular Agents - administration &amp; dosage</subject><subject>Antitubercular Agents - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cohort analysis</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug dosages</subject><subject>Grade 2</subject><subject>Grade 3</subject><subject>Humans</subject><subject>Information Seeking</subject><subject>Isoniazid - administration &amp; dosage</subject><subject>Isoniazid - adverse effects</subject><subject>Latent Tuberculosis - drug therapy</subject><subject>Minicourses</subject><subject>Observational studies</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Rifampin - administration &amp; dosage</subject><subject>Rifampin - adverse effects</subject><subject>Search Strategies</subject><subject>Tuberculosis</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>CJNVE</sourceid><sourceid>M0P</sourceid><recordid>eNpdkF9LwzAUxYMobk6_ggR88aWa5CZp6ovo8B8MRZjPIW0T19G1M0kRv73tNkV8unA4595zfwhhSi4oBXlpfLEoq1AsqrpMGKGQAAGVyj00plyqXuJ8H40JIZBkSqkROgphSQhlSsEhGjGQkkqZjtHza2dDrNoG0yv8uTARG29xXFjcrgc5YNd6HL01sWrecW2ibSKe3-KqcbbYBKsGb4p421wfowNn6mBPdnOC3u7v5tPHZPby8DS9mSUFEyomUojcGcG44jJnXBqe0ZS4DAqbQaaEo8Sw3JCUsBKKXBjrUkakVIoRBqmCCTrf7l379mP4QK96HLauTWPbLmgKglABAKy3nv2zLtvON307TRVTGUtFynuX2roK34bgrdNrX62M_9KU6IG5_stcD8z1lnkfPd0d6PKVLX-DP5DhG2Nbflw</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>Gwee, Amanda</creator><creator>Coghlan, Benjamin</creator><creator>Curtis, Nigel</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201306</creationdate><title>Question 1: what are the options for treating latent TB infection in children?</title><author>Gwee, Amanda ; Coghlan, Benjamin ; Curtis, Nigel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age groups</topic><topic>Antitubercular Agents - administration &amp; dosage</topic><topic>Antitubercular Agents - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cohort analysis</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug dosages</topic><topic>Grade 2</topic><topic>Grade 3</topic><topic>Humans</topic><topic>Information Seeking</topic><topic>Isoniazid - administration &amp; dosage</topic><topic>Isoniazid - adverse effects</topic><topic>Latent Tuberculosis - drug therapy</topic><topic>Minicourses</topic><topic>Observational studies</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Rifampin - administration &amp; dosage</topic><topic>Rifampin - adverse effects</topic><topic>Search Strategies</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gwee, Amanda</creatorcontrib><creatorcontrib>Coghlan, Benjamin</creatorcontrib><creatorcontrib>Curtis, Nigel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Databases</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gwee, Amanda</au><au>Coghlan, Benjamin</au><au>Curtis, Nigel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Question 1: what are the options for treating latent TB infection in children?</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>2013-06</date><risdate>2013</risdate><volume>98</volume><issue>6</issue><spage>468</spage><epage>474</epage><pages>468-474</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>23661667</pmid><doi>10.1136/archdischild-2013-303876</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-9888
ispartof Archives of disease in childhood, 2013-06, Vol.98 (6), p.468-474
issn 0003-9888
1468-2044
language eng
recordid cdi_proquest_miscellaneous_1350153332
source Social Science Premium Collection; Education Collection
subjects Age groups
Antitubercular Agents - administration & dosage
Antitubercular Agents - adverse effects
Child
Child, Preschool
Cohort analysis
Dose-Response Relationship, Drug
Drug dosages
Grade 2
Grade 3
Humans
Information Seeking
Isoniazid - administration & dosage
Isoniazid - adverse effects
Latent Tuberculosis - drug therapy
Minicourses
Observational studies
Patients
Pediatrics
Randomized Controlled Trials as Topic
Rifampin - administration & dosage
Rifampin - adverse effects
Search Strategies
Tuberculosis
title Question 1: what are the options for treating latent TB infection in children?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A20%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Question%201:%20what%20are%20the%20options%20for%20treating%20latent%20TB%20infection%20in%20children?&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Gwee,%20Amanda&rft.date=2013-06&rft.volume=98&rft.issue=6&rft.spage=468&rft.epage=474&rft.pages=468-474&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/archdischild-2013-303876&rft_dat=%3Cproquest_cross%3E1350153332%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c258t-655bfa524846b246a49170f93ce93985f10a2ba0702d3cb5aef72066882023783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1828927574&rft_id=info:pmid/23661667&rfr_iscdi=true